Various trials have shown that high-dose radiotherapy improves prostate-specific antigen (PSA) relapse ... tumor control and decreases the risk of distant metastases in patients with prostate ...

This reality motivates the research focus at HiberCell, where we are looking to complement progress in primary tumor ... dormant DTCs, represents a significant opportunity to prevent cancer ...

enter a state known as "persistence," where dormancy is temporary and reversible. This state allows the cells to begin growing again after the treatment has ended, leading to cancer recurrence.

Moreover, the identification of molecular mechanisms controlling tumor dormancy will perhaps provide a much better means for the avoidance of recurrence. Interestingly, cancer stem cells have ...

there may be potential to keep cancer cells in a dormant state, reducing the risk of late-stage recurrence and improving ...

Researchers from Iwate Medical University and Tohoku University have revealed that it is possible to predict cancer relapse and treatment response by measuring circulating tumor DNA (ctDNA), in ...

specifically the residual – or dormant – cancer cells that survive systemic treatments like chemotherapy and become a cellular reservoir for relapse or metastatic recurrence. He has done extensive ...